Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Spectroscopy and Chromatography
  4. Fast Track Articles
  5. Fast Track Article
image of Developing a New Method for the Estimation of Valsartan (VST) in Pharmaceutical Dosage Samples by Using Diazotization and Coupling Reactions Spectrophotometrically

Abstract

Introduction

A new method for valsartan (VST) estimation in pharmaceutical dosage samples by spectrophotometry was developed.

Method

The method was based on the formation of coloured dye by the diazotization reaction of 3-amino-2-naphthol with sodium nitrite in an acidic medium to form diazonium compounds, which were then coupled with VST in a basic medium.

Results

The drug sample showed linearity in the range 4.6 - 24.2 μgmL-1, and the λ was found at 432nm. Sandell’s sensitivity (9.950×10-3), Molar absorbtivity (Ɛ= 4.377×104), regression equation (y= 0.0775x + 0.0041), correlation coefficient (r2= 0.968), detection limit (DL= 0.668) and quantitation limit (QL= 2.024) were evaluated.

Conclusion

The percentage recovery of the drug samples was found to be 100%. This method successfully determined VST in Pharmaceutical dosage samples.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/csch/10.2174/0129504910320544241018094320
2024-10-24
2024-11-22

  • From This Site

    /content/journals/csch/10.2174/0129504910320544241018094320
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Fischer J. Ganellin C.R. Analogue-based Drug Dis-covery. John Wiley & Sons 2006 470 10.1002/3527608001
    [Google Scholar]
  2. BNF 76 (76 ed.) British national formulary East Smithfield, London Pharmaceutical Press 2018 179
    [Google Scholar]
  3. Valsartan monograph for professionals Available from: https://www.drugs.com/monograph/valsartan.html 2019
  4. Randa H.D. article 26. Renin and Angiotensin The Pharmaco-logical Basis of Therapeutics New York McGraw-Hill Education.New York 2011
    [Google Scholar]
  5. Diovan- valsartan tablet 2019 Available from: https://dailymed. nlm.nih.gov/dailymed/lookup.cfm?setid=c6488119-6547-4abd-bc15-a809b6107d4f#:~:text=Diovan%20(valsartan)%20is%20a%20 nonpeptide,the%20AT1%20receptor%20subtype.
  6. Sacubitril and valsartan monograph for professionals 2019 Available from: https://www.drugs.com/monograph/sacubitril-and-valsaran.html#:~:text=Sacubitril%20and%20valsartan%20(sacubitril%2Fvalsartan,%2Dneprilysin%20inhibitors%20%5BARNIs%5D).
  7. Valsartan pregnancy and breastfeeding warnings 2019 Available from: https://www.drugs.com/pregnancy/valsartan.html
  8. Cohn J.N. Tognoni G. A randomized trial of the angioten-sin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 2001 345 23 1667 1675 10.1056/NEJMoa010713 11759645
    [Google Scholar]
  9. Makani H. Bangalore S. Desouza K.A. Shah A. Messerli F.H. Efficacy and safety of dual blockade of the renin-angiotensin system: Meta-analysis of randomised trials. BMJ 2013 346 jan28 1 f360 10.1136/bmj.f360 23358488
    [Google Scholar]
  10. Zarghi A. Alireza S. Seyed M.F. Hooman M. Rapid quan-tification of valsartan in human plasma by liquid chromatog-raphy using a monolithic column and a fluorescence detec-tion: Application for pharmacokinetic studies. Sci. Pharm. 2008 76 3 439 450 10.3797/scipharm.0808‑01
    [Google Scholar]
  11. Li Y. Zhao Z. Chen X. Wang J. Guo J. Xiao F. HPLC determination of valsartan in human plasma. Yaowu Fenxi Zazhi 2000 20 404 406
    [Google Scholar]
  12. González L. Alonso R.M. Jiménez R.M. A high-performance liquid chromatographic method for screening angiotensin II receptor antagonists in human urine. Chromatographia 2000 52 11-12 735 740 10.1007/BF02490998
    [Google Scholar]
  13. Francotte E. Davatz A. Richert P. Development and valida-tion of chiral high-performance liquid chromatographic meth-ods for the quantitation of valsartan and of the tosylate of va-linebenzyl ester. J. Chromatogr., Biomed. Appl. 1996 686 1 77 83 10.1016/S0378‑4347(96)00242‑3 8953194
    [Google Scholar]
  14. Della G.T.P. Molly M. Ganesan V. A validated stability indicating HPLC method for the determination of Valsartan in tablet dosage forms. J. Appl. Pharm. Sci. 2011 1 97 99
    [Google Scholar]
  15. Nawfal I.N.K. Hanon I.T. Determination of valsartan in its pharmaceutical preparations using high-performance liquid chromatography technique. Int. J. Health Sci. 2022 6 S4 6087 6095 10.53730/ijhs.v6nS4.9532
    [Google Scholar]
  16. Peleshok K. Piponski M. Ajie E.A. Poliak O. Zarivna N. Denefil O. Logoyda L. Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment. Pharmacia 2021 68 1 43 51 10.3897/pharmacia.68.e53631
    [Google Scholar]
  17. Marjan P. Kateryna P. Liliya L. Larysa K. Volodymyr P. Uliana Z. Efficient validated HPLC/UV method for deter-mination of valsartan and atenolol in dosage form and in vitro dissolution studies. Biointerface Res. Appl. Chem. 2020 10 6 6669 6675 10.33263/BRIAC106.66696675
    [Google Scholar]
  18. Vinzuda D.U. Sailor G.U. Sheth N.R. RP-HPLC method for determination of valsartan in tablet dosage form. Int. J. Chemtech Res. 2010 2 1461 1467
    [Google Scholar]
  19. Kumar T.H. Asha C.H. New validated stability indicating RP-HPLC method for simultaneous estimation of amlodipine besylate and valsartan in pharmaceutical formulation. IJPSR 2019 10 5 2633 2643
    [Google Scholar]
  20. Patnaik A. Shetty M. Sahoo S. Nayak D.K. Veliyath S.K. A new RP-HPLC method for the determination of valsartan in bulk and its pharmaceutical formulations with it’s stability indicative studies. Pharma Sci. Monit. 2011 2 43 53
    [Google Scholar]
  21. Sebaiy M.M. El-Adl S.M. Baraka M.M. Hassan A.A. El-Sayed H.M. Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma. BMC Chem. 2022 16 1 70 83 10.1186/s13065‑022‑00864‑4 36127740
    [Google Scholar]
  22. Şatana E. Altınay Ş. Göğer N.G. Özkan S.A. Şentürk Z. Simultaneous determination of valsartan and hydrochlorothi-azide in tablets by first-derivative ultraviolet spectrophotome-try and LC. J. Pharm. Biomed. Anal. 2001 25 5-6 1009 1013 10.1016/S0731‑7085(01)00394‑6 11377086
    [Google Scholar]
  23. Tatar S. Sağlık S. Comparison of UV- and second deriva-tive-spectrophotometric and LC methods for the determina-tion of valsartan in pharmaceutical formulation. J. Pharm. Biomed. Anal. 2002 30 2 371 375 10.1016/S0731‑7085(02)00360‑6 12191724
    [Google Scholar]
  24. Sharma T. Si S.C. A validated gradient stability-indicating LC method for the analysis of valsartan in pharmaceutical dosage form. Int. J. Pharm. Pharm. Sci. 2016 8 9 128 10.22159/ijpps.2016v8i9.12581
    [Google Scholar]
  25. Piao Z.Z. Lee E.S. Tran H.T.T. Lee B.J. Improved analyt-ical validation and pharmacokinetics of valsartan using HPLC with UV detection. Arch. Pharm. Res. 2008 31 8 1055 1059 10.1007/s12272‑001‑1268‑4 18787797
    [Google Scholar]
  26. Sreejanardhanan V. Shine S.R.P.RP UFLC method for estimation of valsartan chemometricaly. World J Adv Res Rev. 2023 18 2 415 426 10.30574/wjarr.2023.18.2.0847
    [Google Scholar]
  27. Haque A. Iqbal M. Alamoudi M. Alam P. A selective and accurate lc-ms/ms method for simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. Separations 2023 10 2 119 131 10.3390/separations10020119
    [Google Scholar]
  28. Mylnikov P.Y. Shchulkin A.V. Seleznev S.V. Pravkin S.K. Abalenikhina Y.V. Yakusheva E.N. Development and validation of a method for quantification of lisinopril, inda-pamide, metoprolol, valsartan, and amoldipine in human blood serum by HPLC-MS/MS. Pharm. Chem. J. 2024 58 3 507 511 10.1007/s11094‑024‑03171‑5
    [Google Scholar]
  29. Faroq O.Q. Akram A.H. Kale M.Q. Ahmed J.M.A. De-velopment and validation of stability indicating nanodrop 2000c uv-vis method for determination of valsartan in phar-maceutical formulations. J Pharm Neg Res 2023 14 3 10.47750/pnr.2023.14.03.120
    [Google Scholar]
  30. Badreldin H.A. Korayem G.B. Alenazy B.A. Aljohani M.H. Alshaya O.A. Al Sulaiman K. Alabdelmuhsin L. Alenazi H. Almutairi D.M. Alanazi F. Alobathani S.K. Alqannam G.M. Almadani O. Aljuhani O. Hafiz A. Aljowaie G. Basha E. Alqahtani T. Alhussein M. Real-world analysis of integration of sacubitril/valsartan into clini-cal practice in Saudi Arabia. Medicine (Baltimore) 2023 102 51 e36699 10.1097/MD.0000000000036699 38134075
    [Google Scholar]
  31. Cagigal E. González L. Alonso R.M. Jiménez R.M. Exper-imental design methodologies to optimise the spectrofluori-metric determination of losartan and valsartan in human urine. Talanta 2001 54 6 1121 1133 10.1016/S0039‑9140(01)00379‑4 18968334
    [Google Scholar]
  32. Gupta K.R. Wadodkar A.R. Wadodkar S.G. UV Spectrophotometric methods for estimation of Valsartan in bulk and tablet dosage form. Int. J. Chemtech Res. 2010 2 985 989
    [Google Scholar]
  33. Monika L.J. Manoj V.G. Shripad K.T. Manish S.J. Development and validation of spectrophotometric methods for simultaneous estimation of valsartan and hydrochlorothi-azide in tablet dosage form Intern. J. Spectrosc. 2014 873819 10.1155/2014/873819
    [Google Scholar]
  34. Sridevi R. Badal K.M. Sameer G.N. Simultaneous spec-trophotometric determination of valsartan and ezetimibe in pharmaceuticals. Tropical J. Pharm. Res. 2011 10 6 809 815
    [Google Scholar]
  35. Madhavi L. Shireesha M. Tuljarani G. Spectrophotometric estimation of valsartan and benazepril hydrochloride in pure and pharmaceutical formulations. Intern J ChemTech Res. 2011 3 4 1830 1834
    [Google Scholar]
  36. Sivasankara G.R. Venkat S.R. Vardhan S.V.M. Rama-chandran D. Development and validation of new UV-spectrophotometric assay method for valsartan in pure and in formulations. J. Chem. Pharm. Res. 2013 5 7 229 232
    [Google Scholar]
  37. Mallegowda S.M. Deepakumari H.N. Revanasiddappa H.D. Spectrophotometric determination of valsartan using p-chloranilic acid as π-acceptor in pure and in dosage forms. J. Appl. Pharm. Sci. 2013 3 1 113 116 10.7324/JAPS.2013.30122
    [Google Scholar]
  38. Kamal A.H. Marie A.A. Hammad S.F. Validated spectro-photometric methods for simultaneous determination of nebivolol hydrochloride and valsartan in their tablet. Microchem. J. 2020 155104741 10.1016/j.microc.2020.104741
    [Google Scholar]
  39. Raul S.K. Padhy G.K. Krishna P.R. Priya B.U.M. UV Spectrophotometric method development and validation for the estimation of valsartan in bulk and pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis 2016 6 3 147 152 10.5958/2231‑5675.2016.00023.5
    [Google Scholar]
  40. Stolarczyk M. Apola A. Maślanka A. Kwiecień A. Opoka W. Spectrophotometric method for simultaneous de-termination of valsartan and substances from the group of statins in binary mixtures. Acta Pharm. 2017 67 4 463 478 10.1515/acph‑2017‑0031 29337671
    [Google Scholar]
  41. Kateryna P. Bohdana B. Liubomyr K. Tetyana K. Olha P. Liliya L. Non- extractive spectrophotometric determina-tion of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia. 2021 68 4 851 858 10.3897/pharmacia.68.e73559
    [Google Scholar]
  42. Peleshok K. Poliak O. Kryskiw L. Sarpong A.F. Zariv-na N. Korobko D. Zahrychuk H. Horlachuk N. Sversti-uk A. Levytska L. Logoyda L. Development and valida-tion of spectrophotometric method for simultaneous estima-tion of valsartan and atenolol in binary mixtures: Application to tablets analysis. Pharmakeftiki. 2021 33 52 60
    [Google Scholar]
  43. Lotfy H.M. Hegazy M.A. Mowaka S. Mohamed E.H. Novel spectrophotometric methods for simultaneous determi-nation of amlodipine, valsartan and hydrochlorothiazide in their ternary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2015 140 495 508 10.1016/j.saa.2014.12.096 25638433
    [Google Scholar]
  44. Tajane S. T. Estimation of valsartan in pharmaceutical formulation by area under curve spectrophotometric method. Intern J Adv Pharmaceutics 2018 7 01 04 10.7439/ijap.v7i1.4550
    [Google Scholar]
  45. Ebrahimi M. Sohrabi M.R. Motiee F. Davallo M. L and D enantiomer binary mixture determination simultaneously by spectrophotometric method without separation step based on artificial neural network and least squares support vector ma-chine in valsartan pharmaceutical production. Optik (Stuttg.) 2021 247168011 10.1016/j.ijleo.2021.168011
    [Google Scholar]
  46. Salih R.F. Rashid Q.N. Spectrophotometric determination of valsartan in pure form and in its pharmaceutical preparations. Al-Qadisiyah Journal of Pure Science 2021 26 4 239 246 10.29350/qjps.2021.26.4.1317
    [Google Scholar]
  47. Sandhyarani K. Visible spectrophotometri determination of valsartan in pharmaceutical formulations. Intern. J. Novel Res. Develop. 2021 7 6 198 203
    [Google Scholar]
  48. Magdy R. Hemdan A. Abdel Ghany M. Fares N. Deter-mination of sacubitril and valsartan binary mixture using dif-ferent eco-friendly spectrophotometric approaches with or without regression equations; greenness and whiteness as-sessments. Archives of Pharmaceutical Sciences Ain Shams University 2023 7 1 1 18 10.21608/aps.2023.170188.1102
    [Google Scholar]
  49. Aashutosh A.D. Pragati G.K. Pooja P.N. Gurappa K.D. Green analytical UV-Vis spectrophotometric method devel-opment of valsartan by using hydrotropic agent. Asian J. Res. Chem 2023 16 5 313 318 10.52711/0974‑4150.2023.00051
    [Google Scholar]
  50. Gayatri D. Saurabh K. Rupali H. Shankar D. Harshal T. Analytical method development by using uv-spectrophotometer for estimation of valsartan in bulk. IJPQA 2024 15 2 854 860
    [Google Scholar]
/content/journals/csch/10.2174/0129504910320544241018094320
Loading
Developing a New Method for the Estimation of Valsartan (VST) in Pharmaceutical Dosage Samples by Using Diazotization and Coupling Reactions Spectrophotometrically
Bentham Science Publishers ; https://doi.org/10.2174/0129504910320544241018094320
/content/journals/csch/10.2174/0129504910320544241018094320
/content/journals/csch/10.2174/0129504910320544241018094320
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: diazotization ; Valsartan(VST) ; pharmaceutical dosage samples ; spectrophotometry ; 3-amino-2-naphthol
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test